TVIS44037334
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
56225131 |
56225131 |
p32.2 |
ENSG00000303110, ENSG00000260971, ENSG00000284686 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037335
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
56091530 |
56091530 |
p32.2 |
ENSG00000297128 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037336
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
5596387 |
5596387 |
p36.31 |
ENSG00000289893 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037337
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
55563590 |
55563590 |
p32.3 |
LINC01755 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037338
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
53640753 |
53640753 |
p32.3 |
GLIS1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037339
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
52729738 |
52729738 |
p32.3 |
ZYG11B |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037340
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
52654240 |
52654240 |
p32.3 |
SHISAL2A |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037341
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
51929727 |
51929727 |
p32.3 |
RAB3B |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037342
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
51335467 |
51335467 |
p32.3 |
TTC39A |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
TVIS44037343
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
1 |
50790265 |
50790265 |
p32.3 |
FAF1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |